论文信息 - A phase III study comparing amrubicin and cisplatin (AP) with irinotecan and cisplatin (IP) for the treatment of extended-stage small cell lung cancer (ED-SCLC): JCOG0509. - 字舞流文

A phase III study comparing amrubicin and cisplatin (AP) with irinotecan and cisplatin (IP) for the treatment of extended-stage small cell lung cancer (ED-SCLC): JCOG0509.

N. Saijo | Y. Ichinose | Y. Ohe | M. Ando | M. Satouchi | Tatsuo Kimura | M. Nishio | N. Yamamoto | T. Tamura | K. Nakagawa | T. Hida | K. Takeda | T. Shibata | S. Atagi | A. Yokoyama | Y. Kotani | K. Minato | H. Fukuda